PTJ
FLGT icon

Paul Tudor Jones’s Fulgent Genetics FLGT Stock Holding History

Paul Tudor Jones’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68M Buy
81,727
+17,640
+28% +$299K ﹤0.01% 2068
2026
Q1 		$1.02M Sell
64,087
-51,961
-45% -$1.13M ﹤0.01% 2362
2025
Q4 		$3.05M Sell
116,048
-55,447
-32% -$1.44M 0.01% 1496
2025
Q3 		$3.88M Sell
171,495
-13,593
-7% -$280K 0.01% 1359
2025
Q2 		$3.68M Buy
185,088
+137,399
+288% +$2.68M 0.01% 1274
2025
Q1 		$806K Buy
+47,689
New +$812K ﹤0.01% 1954
2024
Q4 		– Sell
-17,018
Closed -$370K – 3172
2024
Q3 		$370K Buy
+17,018
New +$381K ﹤0.01% 2190
2022
Q1 		– Sell
-5,681
Closed -$571K – 2234
2021
Q4 		$571K Buy
+5,681
New +$499K 0.01% 1363
2021
Q1 		– Sell
-10,069
Closed -$525K – 1653
2020
Q4 		$525K Buy
+10,069
New +$421K 0.01% 931

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Paul Tudor Jones's FLGT Position: Q2 2026 in Review

Paul Tudor Jones increased its Fulgent Genetics (FLGT) stake by 28% in Q2 2026, buying an estimated $299K and bringing the position to 81,727 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #2068.

Paul Tudor Jones first reported a position in FLGT in Q4 2020 and has held it in 9 quarters since. The position peaked at $3.88M in Q3 2025. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Paul Tudor Jones held 81,727 shares of Fulgent Genetics worth $1.68M as of Q2 2026.
  • Paul Tudor Jones bought 17,640 Fulgent Genetics shares in Q2 2026, an estimated $299K.
  • Fulgent Genetics made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2068 holding.
  • Paul Tudor Jones first reported a position in Fulgent Genetics in Q4 2020 and has held it in 9 quarters since.
  • Paul Tudor Jones's Fulgent Genetics position peaked at $3.88M in Q3 2025.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.